What is Procreate?
Procreate Fertility Center of Virginia operates as a comprehensive infertility clinic headquartered in Chesapeake, VA. The firm distinguishes itself through a patient-centric model that integrates advanced reproductive technologies, including In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI), with accessible financial planning for prospective parents. By maintaining four strategic locations, the company effectively addresses the growing demand for personalized reproductive healthcare, offering tailored solutions for male infertility and inclusive services for the LGBTQ+ community. Their operational framework emphasizes both clinical excellence and the democratization of fertility treatments, positioning them as a critical player in the regional healthcare landscape.
How much funding has Procreate raised?
Procreate has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Procreate
PPP
Public-Private Partnership
What's next for Procreate?
The infusion of capital from this late-stage financing round is expected to catalyze Procreate's operational expansion and technological integration. As the fertility market continues to experience significant tailwinds, the company is likely to prioritize the enhancement of its laboratory facilities and the broadening of its service portfolio to accommodate a larger patient base. Strategic focus will likely shift toward optimizing patient outcomes through data-driven reproductive medicine and potentially exploring further geographic footprint expansion. By leveraging this investment, Procreate aims to solidify its status as a leader in reproductive health, ensuring that high-quality, affordable care remains the cornerstone of its long-term growth trajectory.
See full Procreate company page
